ArticleBMC pulmonary medicine2023

A novel intergenic region (chr2: 30,193,816)-ALK fusion shows sensitivity to Alectinib in lung adenocarcinoma.

Ting Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.